Joseph Kagaayi1, Larry W Chang2, Victor Ssempijja3, M Kate Grabowski4, Robert Ssekubugu5, Gertrude Nakigozi5, Godfrey Kigozi5, David M Serwadda1, Ronald H Gray6, Fred Nalugoda5, Nelson K Sewankambo7, Lisa Nelson8, Lisa A Mills8, Donna Kabatesi8, Stella Alamo8, Caitlin E Kennedy9, Aaron A R Tobian10, John S Santelli11, Anna Mia Ekström12, Helena Nordenstedt13, Thomas C Quinn14, Maria J Wawer6, Steven J Reynolds14. 1. Rakai Health Sciences Program, Entebbe, Uganda; Makerere University School of Public Health, Kampala, Uganda. 2. Rakai Health Sciences Program, Entebbe, Uganda; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Social and Behavioral Interventions Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: lchang8@jhmi.edu. 3. Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, MD, USA. 4. Rakai Health Sciences Program, Entebbe, Uganda; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Rakai Health Sciences Program, Entebbe, Uganda. 6. Rakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. Rakai Health Sciences Program, Entebbe, Uganda; Makerere University School of Medicine, Kampala, Uganda. 8. Centers for Disease Control and Prevention, Entebbe, Uganda. 9. Social and Behavioral Interventions Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 10. Rakai Health Sciences Program, Entebbe, Uganda; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA. 11. Department of Population and Family Health, Columbia Mailman School of Public Health, New York, NY, USA. 12. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. 13. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 14. Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: Targeting combination HIV interventions to locations and populations with high HIV burden is a global priority, but the impact of these strategies on HIV incidence is unclear. We assessed the impact of combination HIV interventions on HIV incidence in four HIV-hyperendemic communities in Uganda. METHODS: We did an open population-based cohort study of people aged 15-49 years residing in four fishing communities on Lake Victoria. The communities were surveyed five times to collect self-reported demographic, behavioural, and service-uptake data. Free HIV testing was provided at each interview, with referral to combination HIV intervention services as appropriate. From November, 2011, combination HIV intervention services were rapidly expanded in these geographical areas. We evaluated trends in HIV testing coverage among all participants, circumcision coverage among male participants, antiretroviral therapy (ART) coverage and HIV viral load among HIV-positive participants, and sexual behaviours and HIV incidence among HIV-negative participants. FINDINGS: From Nov 4, 2011, to Aug 16, 2017, data were collected from five surveys. Overall, 8942 participants contributed 20 721 person-visits; 4619 (52%) of 8942 participants were male. HIV prevalence was 41% (1598 of 3870) in the 2011-12 baseline survey and declined to 37% (1740 of 4738) at the final survey (p<0·0001). 3222 participants who were HIV-negative at baseline, and who had at least one repeat visit, contributed 9477 person-years of follow-up, and 230 incident HIV infections occurred. From the first survey in 2011-12 to the last survey in 2016-17, HIV testing coverage increased from 68% (2613 of 3870) to 96% (4526 of 4738; p<0·0001); male circumcision coverage increased from 35% (698 of 2011) to 65% (1630 of 2525; p<0·0001); ART coverage increased from 16% (254 of 1598) to 82% (1420 of 1740; p<0·0001); and population HIV viral load suppression in all HIV-positive participants increased from 34% (546 of 1596) to 80% (1383 of 1734; p<0·0001). Risky sexual behaviours did not decrease over this period. HIV incidence decreased from 3·43 per 100 person-years (95% CI 2·45-4·67) in 2011-12 to 1·59 per 100 person-years (95% CI 1·19-2·07) in 2016-17; adjusted incidence rate ratio (IRR) 0·52 (95% CI 0·34-0·79). Declines in HIV incidence were similar among men (adjusted IRR 0·53, 95% CI 0·30-0·93) and women (0·51, 0·27-0·96). The risk of incident HIV infection was lower in circumcised men than in uncircumcised men (0·46, 0·32-0·67). INTERPRETATION: Rapid expansion of combination HIV interventions in HIV-hyperendemic fishing communities is feasible and could have a substantial impact on HIV incidence. However, incidence remains higher than HIV epidemic control targets, and additional efforts will be needed to achieve this global health priority. FUNDING: The National Institute of Mental Health, the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Development, the National Cancer Institute, the National Institute for Allergy and Infectious Diseases Division of Intramural Research, Centers for Disease Control and Prevention Uganda, Karolinska Institutet, and the Johns Hopkins University Center for AIDS Research.
BACKGROUND: Targeting combination HIV interventions to locations and populations with high HIV burden is a global priority, but the impact of these strategies on HIV incidence is unclear. We assessed the impact of combination HIV interventions on HIV incidence in four HIV-hyperendemic communities in Uganda. METHODS: We did an open population-based cohort study of people aged 15-49 years residing in four fishing communities on Lake Victoria. The communities were surveyed five times to collect self-reported demographic, behavioural, and service-uptake data. Free HIV testing was provided at each interview, with referral to combination HIV intervention services as appropriate. From November, 2011, combination HIV intervention services were rapidly expanded in these geographical areas. We evaluated trends in HIV testing coverage among all participants, circumcision coverage among male participants, antiretroviral therapy (ART) coverage and HIV viral load among HIV-positive participants, and sexual behaviours and HIV incidence among HIV-negative participants. FINDINGS: From Nov 4, 2011, to Aug 16, 2017, data were collected from five surveys. Overall, 8942 participants contributed 20 721 person-visits; 4619 (52%) of 8942 participants were male. HIV prevalence was 41% (1598 of 3870) in the 2011-12 baseline survey and declined to 37% (1740 of 4738) at the final survey (p<0·0001). 3222 participants who were HIV-negative at baseline, and who had at least one repeat visit, contributed 9477 person-years of follow-up, and 230 incident HIV infections occurred. From the first survey in 2011-12 to the last survey in 2016-17, HIV testing coverage increased from 68% (2613 of 3870) to 96% (4526 of 4738; p<0·0001); male circumcision coverage increased from 35% (698 of 2011) to 65% (1630 of 2525; p<0·0001); ART coverage increased from 16% (254 of 1598) to 82% (1420 of 1740; p<0·0001); and population HIV viral load suppression in all HIV-positive participants increased from 34% (546 of 1596) to 80% (1383 of 1734; p<0·0001). Risky sexual behaviours did not decrease over this period. HIV incidence decreased from 3·43 per 100 person-years (95% CI 2·45-4·67) in 2011-12 to 1·59 per 100 person-years (95% CI 1·19-2·07) in 2016-17; adjusted incidence rate ratio (IRR) 0·52 (95% CI 0·34-0·79). Declines in HIV incidence were similar among men (adjusted IRR 0·53, 95% CI 0·30-0·93) and women (0·51, 0·27-0·96). The risk of incident HIV infection was lower in circumcised men than in uncircumcised men (0·46, 0·32-0·67). INTERPRETATION: Rapid expansion of combination HIV interventions in HIV-hyperendemic fishing communities is feasible and could have a substantial impact on HIV incidence. However, incidence remains higher than HIV epidemic control targets, and additional efforts will be needed to achieve this global health priority. FUNDING: The National Institute of Mental Health, the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Development, the National Cancer Institute, the National Institute for Allergy and Infectious Diseases Division of Intramural Research, Centers for Disease Control and Prevention Uganda, Karolinska Institutet, and the Johns Hopkins University Center for AIDS Research.
Authors: Ingrid V Bassett; Susan Regan; Hlengiwe Mbonambi; Jeffrey Blossom; Stacy Bogan; Benjamin Bearnot; Marion Robine; Rochelle P Walensky; Bright Mhlongo; Kenneth A Freedberg; Hilary Thulare; Elena Losina Journal: AIDS Behav Date: 2015-10
Authors: Larry W Chang; Gertrude Nakigozi; Veena G Billioux; Ronald H Gray; David Serwadda; Thomas C Quinn; Maria J Wawer; Robert C Bollinger; Steven J Reynolds Journal: AIDS Behav Date: 2015-10
Authors: Xiangrong Kong; Anthony Ndyanabo; Fred Nalugoda; Godfrey Kigozi; Joseph Ssekasanvu; Tom Lutalo; David Serwadda; Maria Wawer; Ronald Gray Journal: AIDS Date: 2013-02-20 Impact factor: 4.177
Authors: Noah Kiwanuka; Ali Ssetaala; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Annet Nalutaaya; Paul Kato; Leslie Nielsen; Pontiano Kaleebu; Josephine Nalusiba; Nelson K Sewankambo Journal: J Int AIDS Soc Date: 2013-07-22 Impact factor: 5.396
Authors: Larry W Chang; Mary K Grabowski; Robert Ssekubugu; Fred Nalugoda; Godfrey Kigozi; Betty Nantume; Justin Lessler; Sean M Moore; Thomas C Quinn; Steven J Reynolds; Ronald H Gray; David Serwadda; Maria J Wawer Journal: Lancet HIV Date: 2016-07-09 Impact factor: 12.767
Authors: Larry W Chang; Ismail Mbabali; Xiangrong Kong; Heidi Hutton; K Rivet Amico; Caitlin E Kennedy; Fred Nalugoda; David Serwadda; Robert C Bollinger; Thomas C Quinn; Steven J Reynolds; Ronald Gray; Maria Wawer; Gertrude Nakigozi Journal: Trials Date: 2017-10-23 Impact factor: 2.279
Authors: John S Santelli; Ivy S Chen; Dorean Nabukalu; Tom Lutalo; Esther J Spindler; Larry W Chang; Mary Kate Grabowski; Stephanie A Grilo; Philip Kreniske; Ying Wei; Fred Nalugoda; Susie Hoffman; Mahlet Maru; Sofia Chu; Fred M Ssewamala; William Byansi; Joseph Kagaayi; Maria J Wawer; Ronald H Gray; David Serwadda; Fred Makumbi Journal: Lancet HIV Date: 2022-01 Impact factor: 16.070
Authors: William Ddaaki; Susanne Strömdahl; Ping Teresa Yeh; Anna Mia Ekström; Caitlin E Kennedy; Joseph G Rosen; Jade Jackson; Neema Nakyanjo; Joseph Kagaayi; Godfrey Kigozi; Gertrude Nakigozi; M Kathryn Grabowski; Larry W Chang; Steven J Reynolds; Fred Nalugoda Journal: AIDS Behav Date: 2021-07-09
Authors: Gideon Loevinsohn; Godfrey Kigozi; Joseph Kagaayi; Maria J Wawer; Fred Nalugoda; Larry W Chang; Thomas C Quinn; David Serwadda; Steven J Reynolds; Lisa Nelson; Lisa Mills; Stella Alamo; Gertrude Nakigozi; Geoffrey Kabuye; Robert Ssekubugu; Aaron A R Tobian; Ronald H Gray; M Kathryn Grabowski Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 20.999
Authors: Timothy Mm Farley; Julia Samuelson; M Kate Grabowski; Wole Ameyan; Ronald H Gray; Rachel Baggaley Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 5.396
Authors: Neema R Mosha; Jim Todd; Crispin Mukerebe; Milly Marston; Soledad Colombe; Benjamin Clark; James Beard; Baltazar Mtenga; Emma Slaymaker; Ties Boerma; Basia Zaba; Mark Urassa Journal: Int J STD AIDS Date: 2022-01-18 Impact factor: 1.359
Authors: Eshan U Patel; Sunil S Solomon; Gregory M Lucas; Allison M McFall; Aylur K Srikrishnan; Muniratnam S Kumar; Syed H Iqbal; Shanmugam Saravanan; Nandagopal Paneerselvam; Pachamuthu Balakrishnan; Oliver Laeyendecker; David D Celentano; Shruti H Mehta Journal: Lancet HIV Date: 2021-07-28 Impact factor: 16.070
Authors: M Kate Grabowski; Eshan U Patel; Gertrude Nakigozi; Victor Ssempijja; Robert Ssekubugu; Joseph Ssekasanvu; Anthony Ndyanabo; Godfrey Kigozi; Fred Nalugoda; Ronald H Gray; Sarah Kalibbala; David M Serwadda; Oliver Laeyendecker; Maria J Wawer; Larry W Chang; Thomas C Quinn; Joseph Kagaayi; Aaron A R Tobian; Steven J Reynolds Journal: J Infect Dis Date: 2021-04-08 Impact factor: 7.759
Authors: Oliver Ratmann; Joseph Kagaayi; Matthew Hall; Tanya Golubchick; Godfrey Kigozi; Xiaoyue Xi; Chris Wymant; Gertrude Nakigozi; Lucie Abeler-Dörner; David Bonsall; Astrid Gall; Anne Hoppe; Paul Kellam; Jeremiah Bazaale; Sarah Kalibbala; Oliver Laeyendecker; Justin Lessler; Fred Nalugoda; Larry W Chang; Tulio de Oliveira; Deenan Pillay; Thomas C Quinn; Steven J Reynolds; Simon E F Spencer; Robert Ssekubugu; David Serwadda; Maria J Wawer; Ronald H Gray; Christophe Fraser; M Kate Grabowski Journal: Lancet HIV Date: 2020-01-14 Impact factor: 12.767